Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CD53 |
| Upstream (Parents) |
|---|
| (<<) SLA → CD53 |
| (<<) CD48 → CD53 |
| (<<) EVI2B → CD53 |
| (<<) ARHGAP15 → CD53 |
| (<<) SASH3 → CD53 |
| Downstream (Children) |
|---|
| CD53 → GALM (>>) |
| CD53 → C1orf162 (>>) |
| CD53 → LAPTM5 (>>) |
| CD53 → SLA (>>) |
| CD53 → HLA-DRB6 (>>) |
| CD53 → LAIR1 (>>) |
| CD53 → AIF1 (>>) |
| CD53 → HLA-DRB1 (>>) |
| CD53 → LYZ (>>) |
| CD53 → CTSS (>>) |
| CD53 → CD48 (>>) |
| CD53 → CTSC (>>) |
| CD53 → MPEG1 (>>) |
| CD53 → EVI2B (>>) |
| CD53 → ADAM28 (>>) |
| CD53 → PLEK (>>) |
| CD53 → HLA-DMA (>>) |
| CD53 → RNASE6 (>>) |
| CD53 → GPR65 (>>) |
| CD53 → NCKAP1L (>>) |
| CD53 → PECAM1 (>>) |
| CD53 → CARD16///CASP1 (>>) |
| CD53 → VANGL1 (>>) |
| CD53 → EMP3 (>>) |
